Labcorp's 15-minute chart exhibits bullish KDJ Golden Cross, Marubozu pattern.

Labcorp's 15-minute chart has recently exhibited a KDJ Golden Cross and a Bullish Marubozu pattern, which occurred on August 28, 2025 at 12:15. This suggests a shift in the momentum of the stock price towards an upward trend, indicating potential further growth. As buyers maintain control of the market, the bullish momentum is likely to persist.

Analysts at Bloomberg have issued strong buy recommendations for Labcorp Holdings (LH) and Abivax SA Sponsored ADR (ABVX), with significant price targets indicating substantial upside potential. Both companies have received bullish sentiments from analysts, suggesting they are well-positioned for future growth.

Labcorp Holdings, a healthcare diagnostics company, has shown remarkable growth potential. The company has focused on strategic acquisitions and partnerships to drive revenue growth. In the second quarter of 2025, Labcorp invested $25 million in acquisitions and partnerships, contributing 3.5% to revenue growth. Notable acquisitions such as Incyte Diagnostics and BioReference Health have enhanced its capabilities in key specialty areas like oncology and women's health [1].

Operational efficiency initiatives like the LaunchPad program have also contributed to Labcorp's financial performance. The company successfully achieved targeted savings of $350 million by the end of 2024 and aims to drive $100-$125 million in savings each year [1].

Abivax SA Sponsored ADR, a biotechnology company, has also received a positive outlook from analysts. LifeSci Capital analyst Sam Slutsky maintained a Buy rating on Abivax SA Sponsored ADR with a price target of $116.00. The company's shares closed last Friday at $77.28, indicating a potential for growth [2].

Recently, Labcorp's 15-minute chart exhibited a KDJ Golden Cross and a Bullish Marubozu pattern on August 28, 2025, at 12:15. This suggests a shift in the momentum of the stock price towards an upward trend, indicating potential further growth. As buyers maintain control of the market, the bullish momentum is likely to persist [3].

However, technical indicators for Labcorp show bearish momentum and overbought conditions, indicating a high likelihood of a pullback. The RSI Overbought score of 1 and the WR Overbought score of 6.02 suggest caution [2]. Despite this, analysts remain optimistic due to strong earnings growth and cash flow performance.

Investors should closely monitor these companies for potential opportunities, considering both the bullish analyst sentiments and the mixed technical signals.

References:
[1] https://www.nasdaq.com/articles/it-right-time-hold-labcorp-stock-your-portfolio
[2] https://www.theglobeandmail.com/investing/markets/stocks/LH/pressreleases/34385440/analysts-offer-insights-on-healthcare-companies-labcorp-holdings-lh-and-abivax-sa-sponsored-adr-abvx/
[3] https://www.ainvest.com/news/stock-analysis-labcorp-outlook-mixed-technical-signals-strong-analyst-backing-bullish-fund-flow-trend-2508/